Open lung biopsy in nonresolving ARDS frequently identifies diffuse alveolar damage regardless of the severity stage and may have implications for patient managementClaude Guérin, Jean‐Christophe Richard, Frédérique Bayle et al.|Intensive Care Medicine|2014Cited by 95
Carfilzomib-associated thrombotic microangiopathy: clinical features and outcomesAdrien Joseph, Paul Coppo, Stéphanie Harel et al.|Nephrology Dialysis Transplantation|2024Cited by 8
C3 Glomerulopathy With Concurrent Thrombotic Microangiopathy: Clinical and Immunological FeaturesMelchior Chabannes, Sophie Chauvet, Jérôme Olagne et al.|American Journal of Kidney Diseases|2023Cited by 7
Diagnostic Value of Biological Parameters in Biopsy-Confirmed Thrombotic Microangiopathy–MATRIX Consortium GroupJean‐Michel Halimi, Valentin Maisons, Anna Duval et al.|Kidney International Reports|2025Cited by 6
Anti‐ <scp>ADAMTS13</scp> Antibodies Trajectory is Associated With <scp>ADAMTS13</scp> Recovery in Immune‐Mediated <scp>TTP</scp>Marie Robert, Paul Coppo, Arthur Mageau et al.|American Journal of Hematology|2025Cited by 4